Skip to Main Content

Paper Details

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
J Pathol
16
2022
Author NameAffiliation
Tamara L LotanJohns Hopkins University School of Medicine
Tamara L LotanSidney Kimmel Comprehensive Cancer Center
Tamara L LotanJames Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine
  • 1 - 3

Datasets

Release 1.2